The Last Shall be First? The Federal Coordinating Committee for Comparative Effectiveness Research
This article was originally published in RPM Report
The Department of Health & Human Services announced the 15 member coordinating committee to oversee the $1.1 billion in new spending on comparative effectiveness research included in the stimulus bill. Here are the members, as presented by HHS in its official announcement March 19. There's no way to know for sure who will have the most impact, but it's a safe bet that you can start at the bottom in this case. Ezekiel Emanuel has emerged as a key health policy advisor in the Obama White House-and his brother is the chief of staff.
You may also be interested in...
The stimulus bill provides an unprecedented $1.1 billion for comparative effectiveness research-and does so with none of the key provisions biopharma companies hope to see as the US federal government takes a more active role in the field. The good news: this is only the first round, and there is reason to believe the field is evolving as most pharma companies would want. But this isn't the time for manufacturers to let their guard down.
US President Joe Biden has invoked the Defense Production Act to ramp up COVID-19 tests and personal protective equipment. See what AdvaMed’s CEO Scott Whitaker wrote in a letter to Biden where he asked that the device industry be included in the administration’s decision-making process.